
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5172453
[patent_doc_number] => 20070072886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Method of treating movement disorders using barbituric acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/355339
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10255
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11355339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/355339 | Method of treating movement disorders using barbituric acid derivatives | Feb 15, 2006 | Issued |
Array
(
[id] => 5786719
[patent_doc_number] => 20060205747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Non-sedating barbiturate compounds as neuroprotective agents'
[patent_app_type] => utility
[patent_app_number] => 11/355336
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5803
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11355336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/355336 | Non-sedating barbiturate compounds as neuroprotective agents | Feb 15, 2006 | Issued |
Array
(
[id] => 5732656
[patent_doc_number] => 20060257773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Polyalkylene materials'
[patent_app_type] => utility
[patent_app_number] => 11/352715
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14472
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352715 | Polyalkylene materials | Feb 12, 2006 | Issued |
Array
(
[id] => 5102054
[patent_doc_number] => 20070185316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'METHOD FOR TAGGING OF CARBOHYDRATES WITH ACTIVE METHYLENE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 11/307457
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2495
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307457 | Method for tagging of carbohydrates with active methylene compound | Feb 7, 2006 | Issued |
Array
(
[id] => 7693966
[patent_doc_number] => 20070015720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Modulation of endogenous AICAR levels for the treatment of diabetes and obesity'
[patent_app_type] => utility
[patent_app_number] => 11/347811
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9215
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347811
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347811 | Modulation of endogenous AICAR levels for the treatment of diabetes and obesity | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5160610
[patent_doc_number] => 20070173654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Methods for dehydration of sugars'
[patent_app_type] => utility
[patent_app_number] => 11/341968
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2882
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341968 | Methods for dehydration of sugars and sugar alcohols | Jan 25, 2006 | Issued |
Array
(
[id] => 4753176
[patent_doc_number] => 20080161251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Pharmaceutical Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/814456
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 77568
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814456
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814456 | Pharmaceutical Compounds | Jan 19, 2006 | Abandoned |
Array
(
[id] => 5844515
[patent_doc_number] => 20060122207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Imidazol derivatives as Raf kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/333003
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7070
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333003 | Imidazol derivatives as Raf kinase inhibitors | Jan 16, 2006 | Abandoned |
Array
(
[id] => 4477402
[patent_doc_number] => 07906492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Therapy-enhancing glucan'
[patent_app_type] => utility
[patent_app_number] => 11/334763
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12284
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11334763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/334763 | Therapy-enhancing glucan | Jan 16, 2006 | Issued |
Array
(
[id] => 5570271
[patent_doc_number] => 20090253649
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-10-08
[patent_title] => 'Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/813729
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5961
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0253/20090253649.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813729 | Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof | Jan 10, 2006 | Issued |
Array
(
[id] => 5570271
[patent_doc_number] => 20090253649
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-10-08
[patent_title] => 'Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/813729
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5961
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0253/20090253649.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813729 | Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof | Jan 10, 2006 | Issued |
Array
(
[id] => 5609123
[patent_doc_number] => 20060270639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs'
[patent_app_type] => utility
[patent_app_number] => 11/329636
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9835
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270639.pdf
[firstpage_image] =>[orig_patent_app_number] => 11329636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329636 | Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs | Jan 9, 2006 | Abandoned |
Array
(
[id] => 222553
[patent_doc_number] => 07610100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Methods and systems for treating osteoarthritis'
[patent_app_type] => utility
[patent_app_number] => 11/322763
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 9809
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/610/07610100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322763 | Methods and systems for treating osteoarthritis | Dec 29, 2005 | Issued |
Array
(
[id] => 5777345
[patent_doc_number] => 20060105985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Treatment of mucositis'
[patent_app_type] => utility
[patent_app_number] => 11/318677
[patent_app_country] => US
[patent_app_date] => 2005-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7841
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11318677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/318677 | Treatment of mucositis | Dec 26, 2005 | Abandoned |
Array
(
[id] => 5348776
[patent_doc_number] => 20090004137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv'
[patent_app_type] => utility
[patent_app_number] => 11/794032
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17775
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004137.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794032 | Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv | Dec 21, 2005 | Abandoned |
Array
(
[id] => 4533778
[patent_doc_number] => 07871987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Ester derivatives of ascorbic and 2-keto acid saccharides'
[patent_app_type] => utility
[patent_app_number] => 11/792460
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10570
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871987.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792460 | Ester derivatives of ascorbic and 2-keto acid saccharides | Dec 15, 2005 | Issued |
Array
(
[id] => 5656474
[patent_doc_number] => 20060142210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture'
[patent_app_type] => utility
[patent_app_number] => 11/304284
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8543
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304284 | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | Dec 14, 2005 | Issued |
Array
(
[id] => 4887491
[patent_doc_number] => 20080261823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides'
[patent_app_type] => utility
[patent_app_number] => 11/792968
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6327
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792968 | Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides | Dec 8, 2005 | Abandoned |
Array
(
[id] => 5254053
[patent_doc_number] => 20070135509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Indolone compounds useful to treat cognitive impairment'
[patent_app_type] => utility
[patent_app_number] => 11/298116
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11945
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298116 | Indolone compounds useful to treat cognitive impairment | Dec 8, 2005 | Abandoned |
Array
(
[id] => 348890
[patent_doc_number] => 07495006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => '2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/301326
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 45367
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301326 | 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation | Dec 7, 2005 | Issued |